Deutsch English Français

Contact

EP3296407

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...

Extract from the Register of European Patents

EP About this file: EP3296407

EP3296407 - MUTATIONS OF THE PIK3CA GENE IN HUMAN CANCERS [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 27.03.2020 Database last updated on 31.03.2026
Former	The patent has been granted Status updated on 19.04.2019
Former	Grant of patent is intended Status updated on 18.12.2018
Former	Request for examination was made Status updated on 31.08.2018
Former	The application has been published Status updated on 16.02.2018
Most recent event Tooltip	01.07.2022	Lapse of the patent in a contracting state	published on 03.08.2022 [2022/31]
Applicant(s)	For all designated states The Johns Hopkins University 3400 North Charles Street Baltimore, MD 21218 / US
	[2018/12]
Inventor(s)	01 / SAMUELS, Yardena 10921 Deborah Drive Potomac, MD 20854 / US
	02 / VELCULESCU, Victor 14064 Big Branch Drive Dayton, MD 21036 / US
	03 / KINZLER, Kenneth 616 Ponte Villas N. Baltimore, MD 21230-3959 / US
	04 / VOGELSTEIN, Bert 3700 Breton Way Baltimore, MD 21208 / US
	[2019/21]
Former [2018/12]	01 / SAMUELS, Yardena 10921 Deborah Drive Potomac, MD Maryland MD 20854 / US
	02 / VELCULESCU, Victor 14064 Big Branch Drive Dayton, MD Maryland MD 21036 / US
	03 / KINZLER, Kenneth 616 Ponte Villas N. Baltimore, MD Maryland MD 21230-3959 / US
	04 / VOGELSTEIN, Bert 3700 Breton Way Baltimore, MD Maryland MD 21208 / US
Representative(s)	Tombling, Adrian George Withers & Rogers LLP 2 London Bridge London SE1 9RA / GB
	[N/P]
Former [2018/12]	Tombling, Adrian George Withers & Rogers LLP 4 More London Riverside London SE1 2AU / GB
Application number, filing date	17197306.8	18.02.2005
	[2018/12]
Priority number, date	US20040548886P	02.03.2004 Original published format: US 548886 P
	[2018/12]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	EP3296407
	Date:	21.03.2018
	Language:	EN
	[2018/12]
	Type:	B1 Patent specification
	No.:	EP3296407
	Date:	22.05.2019
	Language:	EN
	[2019/21]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	05.02.2018
Classification	IPC:	C12Q1/6886	[2018/51]
	CPC:	C12Q1/6886 (EP,US); A61K48/005 (US); A61P35/00 (EP); A61P43/00 (EP); C12Q2600/156 (EP,US)
	Former IPC [2018/12]	C12Q1/68
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2018/40]
Former [2018/12]	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR
Title	German:	MUTATIONEN DES PIK3CA-GENS IN MENSCHLICHEN KREBSEN	[2018/12]
	English:	MUTATIONS OF THE PIK3CA GENE IN HUMAN CANCERS	[2018/12]
	French:	MUTATIONS DU GÈNE PIK3CA DANS LES CANCERS HUMAINS	[2018/12]
Examination procedure	19.10.2017	Date on which the examining division has become responsible
	23.08.2018	Amendment by applicant (claims and/or description)
	23.08.2018	Examination requested [2018/40]
	19.12.2018	Communication of intention to grant the patent
	11.04.2019	Fee for grant paid
	11.04.2019	Fee for publishing/printing paid
	11.04.2019	Receipt of the translation of the claim(s)
Parent application(s) Tooltip	EP05723277.9 / EP1730303
	EP12164819.0 / EP2497836
	EP15150891.8 / EP2896703
Divisional application(s)	EP19175606.3 / EP3556866
Opposition(s)	25.02.2020	No opposition filed within time limit [2020/18]
Fees paid	Renewal fee
	19.10.2017	Renewal fee patent year 03
	19.10.2017	Renewal fee patent year 04
	19.10.2017	Renewal fee patent year 05
	19.10.2017	Renewal fee patent year 06
	19.10.2017	Renewal fee patent year 07
	19.10.2017	Renewal fee patent year 08
	19.10.2017	Renewal fee patent year 09
	19.10.2017	Renewal fee patent year 10
	19.10.2017	Renewal fee patent year 11
	19.10.2017	Renewal fee patent year 12
	19.10.2017	Renewal fee patent year 13
	27.02.2018	Renewal fee patent year 14
	27.02.2019	Renewal fee patent year 15
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	IS	22.09.2019
	[2022/31]
Documents cited:	Search	[A] PHILP AMANDA J ET AL: "The phosphatidylinositol 3'-kinase p85alpha gene is an oncogene in human ovarian and colon tumors", CANCER RESEARCH, AACR - AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, vol. 61, no. 20, 15 October 2001 (2001-10-15), pages 7426 - 7429, XP002505603, ISSN: 0008-5472
		[A] ZHANG LIN ET AL: "The oncogene phosphatidylinositol 3'-kinase catalytic subunit alpha promotes angiogenesis via vascular endothelial growth factor in ovarian carcinoma.", CANCER RESEARCH, vol. 63, no. 14, 15 July 2003 (2003-07-15), pages 4225 - 4231, XP002539224, ISSN: 0008-5472
		[A] MA Y-Y ET AL: "PIK3CA as an oncogene in cervical cancer", ONCOGENE, NATURE PUBLISHING GROUP, GB BASINGSTOKE, HANTS, vol. 19, no. 23, 25 May 2000 (2000-05-25), pages 2739 - 2744, XP002459619, ISSN: 0950-9232 DOI: http://dx.doi.org/10.1038/sj.onc.1203597
		[A] SHAYESTEH LALEH ET AL: "PIK3CA is implicated as an oncogene in ovarian cancer", NATURE GENETICS, vol. 21, no. 1, January 1999 (1999-01-01), pages 99 - 102, XP002539225, ISSN: 1061-4036 DOI: http://dx.doi.org/10.1038/5042
	by applicant	US6075181
		HANNON, GJ: "RNA Interference", NATURE, vol. 418, 2002, pages 244 - 251, XP002979088, DOI: doi:10.1038/418244a DOI: http://dx.doi.org/10.1038/418244a
		BERNSTEIN E ET AL.: "The rest is silence", RNA, vol. 7, 2002, pages 1509 - 1521, XP009010244
		HUTVAGNER G ET AL.: "RNAi: Nature abhors a double-strand", CURR. OPIN. GENETICS & DEVELOPMENT, vol. 12, pages 225 - 232, XP002329959, DOI: doi:10.1016/S0959-437X(02)00290-3 DOI: http://dx.doi.org/10.1016/S0959-437X(02)00290-3
		BRUMMELKAMP: "A system for stable expression of short interfering RNAs in mammalian cells", SCIENCE, vol. 296, 2002, pages 550 - 553, XP002626048, DOI: doi:10.1126/science.1068999 DOI: http://dx.doi.org/10.1126/science.1068999
		LEE NS; DOHJIMA T; BAUER G; LI H; LI M-J; EHSANI A; SALVATERRA P; ROSSI J.: "Expression of small interfering RNAs targeted against H1V-1 rev transcripts in human cells", NATURE BIOTECHNOL., vol. 20, 2002, pages 500 - 505
		MIYAGISHI M; TAIRA K: "U6-promoter-driven siRNAs with four uridine 3' overhangs efficiently suppress targeted gene expression in mammalian cells", NATURE BIOTECHNOL., vol. 20, 2002, pages 497 - 500, XP002961100, DOI: doi:10.1038/nbt0502-497 DOI: http://dx.doi.org/10.1038/nbt0502-497
		PADDISON PJ; CAUDY AA; BEMSTEIN E; HANNON GJ; CONKLIN DS: "Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells", GENES & DEV., vol. 16, 2002, pages 948 - 958
		PAUL CP; GOOD PD; WINER I; ENGELKE DR: "Effective expression of small interfering RNA in human cells", NATURE BIOTECHNOL., vol. 20, 2002, pages 505 - 508, XP001121066, DOI: doi:10.1038/nbt0502-505 DOI: http://dx.doi.org/10.1038/nbt0502-505
		SUI G; SOOHOO C; AFFAR E-B; GAY F; SHI Y; FORRESTER WC; SHI Y: "A DNA vector-based RNAi technology to suppress gene expression in mammalian cells", PROC. NATL. ACAD. SCI, USA, vol. 99, no. 6, 2002, pages 5515 - 5520, XP002964701, DOI: doi:10.1073/pnas.082117599 DOI: http://dx.doi.org/10.1073/pnas.082117599
		YU J-Y; DERUITER SL; TURNER DL: "RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells", PROC. NATL, ACAD. SCI. USA, vol. 99, no. 9, 2002, pages 6047 - 6052, XP002332096, DOI: doi:10.1073/pnas.092143499 DOI: http://dx.doi.org/10.1073/pnas.092143499
		NINA D. RUSSEL; JOSE R. F. CORVALAN; MICHAEL L. GALLO; C, GEOFFREY DAVIS; LIISE-ANNE PIROFSKI: "Production of Protective Human Antipneumococcal Antibodies by Transgenic Mice with Human Immunoglobulin Loci", INFECTION AND IMMUNITY, April 2000 (2000-04-01), pages 1820 - 1826, XP002317135, DOI: doi:10.1128/IAI.68.4.1820-1826.2000 DOI: http://dx.doi.org/10.1128/IAI.68.4.1820-1826.2000
		MICHAEL L. GALLO; VLADIMIR E. IVANOV; AYA JAKOBOVITS; C. GEOFFREY DAVIS: "The human immunoglobulin loci introduced into mice: V (D) and J gene segment usage similar to that of adult humans", EUROPEAN JOURNAL OF IMMUNOLOGY, vol. 30, 2000, pages 534 - 540, XP003035688 DOI: http://dx.doi.org/10.1002/1521-4141(200002)30:2<534::AID-IMMU534>3.0.CO;2-P
		LARRY L. GREEN: "Antibody engineering via genetic engineering of the mouse: XenoMouse strains are a vehicle for the facile generation of therapeutic human monoclonal antibodies", JOURNAL OF IMMUNOLOGICAL METHODS, vol. 231, 1999, pages 11 - 23
		YANG X-D; CORVALAN JRF; WANG P; ROY CM-N; DAVIS CG: "Fully Human Anti-interleukin-8 Monoclonal Antibodies: Potential Therapeutics for the Treatment of Inflammatory Disease States", JOURNAL OF LEUKOCYTE BIOLOGY, vol. 66, 1999, pages 401 - 410, XP001014326 DOI: http://dx.doi.org/10.1002/jlb.66.3.401
		YANG X-D; JIA X-C; CORVALAN JRF; WANG P; CG DAVIS; JAKOBOVITS A: "Eradication of Established Tumors by a Fully Human Monoclonal Antibody to the Epidermal Growth Factor Receptor without Concomitant Chemotherapy", CANCER RESEARCH, vol. 59, no. 6, 1999, pages 1236 - 1243
		ADVANCED DRUG DELIVERY REVIEWS, vol. 31, 1998, pages 33 - 42
		GREEN L; JAKOBOVITS A: "Regulation of B cell development by variable gene complexity in mice reconstituted with human immunoglobulin yeast artificial chromosomes", J. EXP. MED., vol. 188, no. 3, 1998, pages 483 - 495, XP055268111, DOI: doi:10.1084/jem.188.3.483 DOI: http://dx.doi.org/10.1084/jem.188.3.483
		JAKOBOVITS A: "The long-awaited magic bullets: therapeutic human monoclonal antibodies from transgenic mice", EXP. OPIN, INVEST. DRUGS, vol. 7, no. 4, 1998, pages 607 - 614, XP002084509, DOI: doi:10.1517/13543784.7.4.607 DOI: http://dx.doi.org/10.1517/13543784.7.4.607
		TSUDA H; MAYNARD-CURRIE K; REID L; YOSHIDA T; EDAMURA K; MAEDA N; SMITHIES 0; JAKOBOVITS A: "Inactivation of Mouse HPRT locus by a 203-bp retrotransposon insertion and. a 55-kb gene-targeted deletion: establishment of new HPRT-Deficient mouse embryonic stem cell lines", GENOMICS, vol. 42, 1997, pages 413 - 421, XP000770318, DOI: doi:10.1006/geno.1997.4771 DOI: http://dx.doi.org/10.1006/geno.1997.4771
		SHERMAN-GOLD, R: "Monoclonal Antibodies: The Evolution from '80s Magic Bullets To Mature, Mainstream Applications as Clinical Therapeutics", GENETIC ENGINEERING NEWS, vol. 17, no. 14, August 1997 (1997-08-01)
		MENDEZ M; GREEN L; CORVALAN J; JIA X-C; MAYNARD-CUNIC C; YANG X-D; GALLO M; LOUIE D; LEE D; ERICKSON K: "Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice", NATURE GENETICS, vol. 15, 1997, pages 146 - 156
		JAKOBOVITS A: "Mice engineered with human immunoglobulin YACs: A new technology for production of fully human antibodies for autoimmunity therapy", WEIR'S HANDBOOK OF EXPERIMENTAL IMMUNOLOGY, THE INTEGRATED IMMUNE SYSTEM, vol. IV, 1996, pages 194.1 - 194.7
		JAKOBOVITS A: "Production of fully human antibodies by transgenic mice", CURRENT OPINION IN BIOTECHNOLOGY, vol. 6, no. 5, 1995, pages 561 - 566, XP055000023, DOI: doi:10.1016/0958-1669(95)80093-X DOI: http://dx.doi.org/10.1016/0958-1669(95)80093-X
		MENDEZ M; ABDERRAHIM H; NOGUCHI M; DAVID N; HARDY M; GREEN L; TSUDA H; YOAST S; MAYNARD-CURRIE C; GARZA D: "Analysis of the structural integrity of YACs comprising human immunoglobulin genes in yeast and in embryonic stem cells", GENOMICS, vol. 26, 1995, pages 294 - 307, XP004796691, DOI: doi:10.1016/0888-7543(95)80214-7 DOI: http://dx.doi.org/10.1016/0888-7543(95)80214-7
		JAKOBOVITS A. YAC VECTORS: "Humanizing the mouse genome", CURRENT BIOLOGY, vol. 4, no. 8, 1994, pages 761 - 763, XP024248830, DOI: doi:10.1016/S0960-9822(00)00172-X DOI: http://dx.doi.org/10.1016/S0960-9822(00)00172-X
		ARBONES M; ORD D; LEY K; RATECH H; MAYNARD-CURRY K; OTTEN G; CAPON D; TEDDER T: "Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice", IMMUNITY, vol. 1, no. 4, 1994, pages 247 - 260, XP024247797, DOI: doi:10.1016/1074-7613(94)90076-0 DOI: http://dx.doi.org/10.1016/1074-7613(94)90076-0
		GREEN L; HARDY M; MAYNARD-CURRY K; TSUDA H; LOUIE D; MENDEZ M; ABDERRAHIM H; NOGUCBI M; SMITH D; ZEUG Y: "Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs", NATURE GENETICS, vol. 7, no. 1, 1994, pages 13 - 21
		JAKOBOVITS A; MOORE A; GREEN L; VERGARA G; MAYNARD-CURRY K; AUSTIN H; KLAPHOLZ S: "Germ-line transmission and expression of a human-derived yeast artificial chromosome", NATURE, vol. 362, no. 6417, 1993, pages 255 - 258, XP002025628, DOI: doi:10.1038/362255a0 DOI: http://dx.doi.org/10.1038/362255a0
		JAKOBOVITS A; VERGARA G; KENNEDY J; HALES J; MCGUINNESS R; CASENTINI-BOROCZ D; BRENNER D; OTTEN G: "Analysis of homozygous mutant chimeric mice: deletion of the immunoglobulin heavy-chain joining region blocks B-' cell development and antibody production", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 90, no. 6, 1993, pages 2551 - 2555, XP000673147, DOI: doi:10.1073/pnas.90.6.2551 DOI: http://dx.doi.org/10.1073/pnas.90.6.2551
		TRUITT ET AL., J. EXP. MED., vol. 179, 1994, pages 1071 - 1076
		R. KATSO ET AL., ANNU REV CELLDEV BIOL, vol. 17, 2001, pages 615 - 675
		I. VIVANCO; C. L. SAWYERS, NAT REV CANCER, vol. 2, July 2002 (2002-07-01), pages 489 - 501
		W. A. PHILLIPS; F. ST CLAIR; A. D. MUNDAY; R, J, THOMAS; C. A. MITCHELL, CANCER, vol. 83, 1 July 1998 (1998-07-01), pages 41 - 47
		E. S. GERSHTEIN; V. A. SHATSKAYA; V. D. ERMILOVA; N. E. KUSHLINSKY; M. A. KRASIL'NIKOV, CLIN CHIM ACTA, vol. 287, September 1999 (1999-09-01), pages 59 - 67
		B. VANHAESEBROECK; M. D. WATERFIELD, EXP CELL RES, vol. 253, 25 November 1999 (1999-11-25), pages 239 - 254
		S. DJORDJEVIC; P. C. DRISCOLL, TRENDS BIOCHEM SCI, vol. 27, August 2002 (2002-08-01), pages 426 - 432
		T, L. WANG ET AL., PROC NATL ACAD SCI USA, vol. 99, 2002, pages 3076 - 3080
		J. L. BOS ET AL., NATURE, vol. 327, 1987, pages 293 - 297
		H. DAVIES ET AL., NATURE, 9 June 2002 (2002-06-09)
		H, RAJAGOPALAN ET AL., NATURE, vol. 418, 2002, pages 934
		P. J. MORIN ET AL., SCIENCE, vol. 275, 1997, pages 1787 - 1790
		A, BARDELLI ET AL., SCIENCE, vol. 300, 9 May 2003 (2003-05-09), pages 949
		J. LI ET AL., SCIENCE, vol. 275, 1997, pages 1943 - 1947
		P. A, STECK ET AL., NAT GENET, vol. 15, 1997, pages 356 - 362
		T. MAEHAMA; J. B. DIXON, J BIOL CHEM, vol. 273, 29 May 1998 (1998-05-29), pages 13375 - 13378
		M. P. MYERS ET AL., PROC NATL ACAD SCI USA, vol. 95, 10 November 1998 (1998-11-10), pages 13513 - 13518
		L. SHAYESTEH ET AL., NAT GENET, vol. 21, January 1999 (1999-01-01), pages 99 - 102
		J. Q. CHENG ET AL., PROC NATL ACAD SCI USA, vol. 89, 1 October 1992 (1992-10-01), pages 9267 - 9271
		L. HU; J. HOFMANN; Y. LU; G. B. MILLS; R. B. JAFFE, CANCER RES, vol. 62, 15 February 2002 (2002-02-15), pages 1087 - 1092
		J. LUO; B. D. MANNING; L. C. CANTLEY, CANCER CELL, vol. 4, 2003, pages 257 - 262

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.